Company Filing History:
Years Active: 1991-1994
Title: Innovator in Biotechnology: The Patented Works of Elisabetta Franchi
Introduction: Elisabetta Franchi, based in Milan, Italy, is a renowned inventor recognized for her significant contributions to the field of biotechnology. With a strong focus on genetic engineering and molecular biology, she has successfully patented three innovative technologies that enhance the production of human growth hormone.
Latest Patents: Franchi's latest patents include two pivotal innovations related to plasmid vectors and their applications in Bacillus species for cloning and synthesizing human growth hormone. The first patent is centered around a plasmid vector designed for expression in Bacillus, detailing a method for cloning the structural gene that codes for human growth hormone. This recombinant DNA molecule enables the insertion of the gene into Bacillus strains, allowing the cultivation of transformed strains to produce the hormone effectively. The second patent outlines a hybrid plasmid capable of inducing natural expression and secretion of human growth hormone. The method described ensures that Bacillus subtilis cells transformed by the hybrid plasmid can yield hGH with the correct amino acid sequence, making it particularly valuable for therapeutic applications in humans.
Career Highlights: Elisabetta Franchi's career is marked by her dedication to advancing biotechnology. Her work at Eniricerche S.p.a. has been instrumental in bridging scientific research with practical applications in healthcare, particularly through her innovative patented methodologies for hormone production.
Collaborations: Throughout her career, Franchi has partnered with notable colleagues, including Guido Grandi and Federico Maisano. Their collaborative efforts have further propelled advancements in research and development within the biotechnological landscape.
Conclusion: Elisabetta Franchi stands out as a pioneering inventor whose patents significantly contribute to biopharmaceutical development. Her innovative work continues to shape the future of biotechnology and offers promising solutions for human health needs.